RxSight (RXST) Earnings Date, Estimates & Call Transcripts $7.19 -0.60 (-7.70%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$7.19 0.00 (0.00%) As of 08/8/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RxSight Earnings Summary RxSight announced Guidance Update earnings on August 7, 2025, reporting an EPS of -$0.08, which missed analysts' consensus estimates of -$0.04 by $0.04. Quarterly revenue fell 3.7% year-over-year to $33.64 million, below analysts' expectations of $39.78 million. With a trailing EPS of -$0.67, RxSight's earnings are expected to grow next year, from ($0.70) to ($0.39) per share. Latest Guidance Update Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) -$0.04 Actual EPS (Aug. 7) -$0.08 Missed By -$0.04 Actual Revenue (Aug. 7) $33.64MGuidance Update Earnings ResourcesGuidance Update Earnings ReportConference Call Transcript & Audio Press Release Slide DeckSlide DeckFull Screen Slide DeckPowered by Get RxSight Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on RxSight and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRXST Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RXST Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. RxSight Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.70) EPSNext Year EPS Consensus Estimate ($0.39) EPS RxSight Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Guidance Update-$0.04-$0.08 -$0.04-$0.29$39.78M$33.64M5/7/2025Q1 2025-$0.03-$0.03--$0.20$38.74M$37.90M2/25/2025Q4 2024$0.10-$0.15 -$0.25-$0.15$40.23M$40.21M11/7/2024Q3 2024$0.0170-$0.16 -$0.1770-$0.16$35.15M$35.31M8/5/2024Q2 2024-$0.22-$0.16+$0.06-$0.16$32.33M$34.89M5/6/2024Q1 2024-$0.1680-$0.25 -$0.0820-$0.25$27.56M$29.51M2/28/2024Q4 2023-$0.36-$0.26+$0.10-$0.26$28.60M$28.58M11/9/2023Q3 2023-$0.42-$0.35+$0.07-$0.35$20.81M$22.20M RxSight Earnings - Frequently Asked Questions When did RxSight announce their last quarterly earnings? RxSight (NASDAQ:RXST) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on RXST's earnings history. What guidance has RxSight issued on next quarter's earnings? RxSight updated its FY 2025 earnings guidance on Tuesday, July, 8th. The company issued revenue guidance of $120.0 million-$130.0 million, compared to the consensus revenue estimate of $167.6 million. Did RxSight beat their earnings estimates last quarter? In the previous quarter, RxSight (NASDAQ:RXST) missed the analysts' consensus estimate of ($0.04) by $0.04 with a reported earnings per share (EPS) of ($0.08). Learn more on analysts' earnings estimate vs. RXST's actual earnings. How can I listen to RxSight's earnings conference call? The conference call for RxSight's latest earnings report can be listened to online. Listen to Conference Call How can I read RxSight's conference call transcript? The conference call transcript for RxSight's latest earnings report can be read online. Read Transcript How much revenue does RxSight generate each year? RxSight (NASDAQ:RXST) has a recorded annual revenue of $139.93 million. How much profit does RxSight generate each year? RxSight (NASDAQ:RXST) has a recorded net income of -$27.45 million. RXST has generated -$0.67 earnings per share over the last four quarters. What is RxSight's EPS forecast for next year? RxSight's earnings are expected to grow from ($0.70) per share to ($0.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies NovoCure Earnings Date Establishment Labs Earnings Date MiMedx Group Earnings Date Tandem Diabetes Care Earnings Date BioLife Solutions Earnings Date Pulse Biosciences Earnings Date InMode Earnings Date iRadimed Earnings Date Kestra Medical Technologies Earnings Date SiBone Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:RXST) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
